Literature DB >> 21857822

Surgical risks in patients on inflammatory bowel disease medications.

Bret A Lashner1.   

Abstract

Entities:  

Year:  2011        PMID： 21857822      PMCID： PMC3127026     

Source DB:  PubMed          Journal:  Gastroenterol Hepatol (N Y)        ISSN： 1554-7914


× No keyword cloud information.
  5 in total

1.  Infliximab in ulcerative colitis is associated with an increased risk of postoperative complications after restorative proctocolectomy.

Authors:  I J Mor; J D Vogel; A da Luz Moreira; B Shen; J Hammel; F H Remzi
Journal:  Dis Colon Rectum       Date:  2008-06-07       Impact factor: 4.585

2.  Meta-analysis: pre-operative infliximab treatment and short-term post-operative complications in patients with ulcerative colitis.

Authors:  Z Yang; Q Wu; K Wu; D Fan
Journal:  Aliment Pharmacol Ther       Date:  2009-11-19       Impact factor: 8.171

3.  Does infliximab increase complications after surgery for inflammatory bowel disease?

Authors:  Stefan D Holubar; Robert R Cima; John H Pemberton
Journal:  F1000 Med Rep       Date:  2009-01-21

4.  Use of infliximab within 3 months of ileocolonic resection is associated with adverse postoperative outcomes in Crohn's patients.

Authors:  Kweku A Appau; Victor W Fazio; Bo Shen; James M Church; Bret Lashner; Feza Remzi; Aaron Brzezinski; Scott A Strong; Jeffrey Hammel; Ravi P Kiran
Journal:  J Gastrointest Surg       Date:  2008-08-15       Impact factor: 3.452

5.  Corticosteroids but not infliximab increase short-term postoperative infectious complications in patients with ulcerative colitis.

Authors:  M Ferrante; A D'Hoore; S Vermeire; S Declerck; M Noman; G Van Assche; I Hoffman; P Rutgeerts; F Penninckx
Journal:  Inflamm Bowel Dis       Date:  2009-07       Impact factor: 5.325
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.